Top Bulls Reasons To Buy — Vote below!

Add a New Bulls Reason

Company: Orexigen Therapeutics (OREX)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
1 votes

  Bullish on Obesity

If the FDA approves, American demand for this weight loss drug will skyrocket. Approximately 2/3 of Americans are overweight or obese and this will open up the flood gates for demand. OREX is probably a strong play! The news of the FDA advisory panel approving shot up the price. Wait until the FDA approves.

(100 character max) Cancel
100%
agree
1 votes

  75% Chance of FDA Approval.

Huge Short Position to cover. Possible TakeOver Candidate. 1 Billion Contract Partner. 1st Overweight Drug to Clear FDA Panel Review in over a decade.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki